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Summary
Background.— Rarely, hypoxaemia is associated with shunt reversal at the atrial level. Closure
by interventional catheterization is the treatment of choice but indications and results have
been studied insufﬁciently.
Purpose.— To describe our experience with interventional closure of atrial right-to-left shunts
described as hypoxaemic and the impact on patient oxygenation and clinical status.
Method.— Retrospective study in two referral centres, including all patients undergoing closure
of interatrial right-to-left shunt associated with hypoxaemia.
Results.— Since 2001, 21 consecutive patients underwent interventional shunt closure using
the ‘‘Amplatzer® device’’; two patients had atrial septal defect and 19 had patent foramen
ovale. Three patients had minor adverse events; two patients have a tiny residual shunt. Tran-
scutaneous oxygen saturation and partial oxygen pressure increased signiﬁcantly from 86± 5
to 95± 3% (p < 0.001) and from 49.8± 6.8 to 82.9± 30.4mmHg (p = 0.001), respectively. Seven-
teen (80%) patients reported clinical improvement. However, patients with chronic respiratory
Abbreviations: ASD, atrial septal defect; CRI, chronic respiratory insufﬁciency; NYHA, New York Heart Association; PaO2, partial
oxygen arterial pressure; PFO, patent foramen ovale; SaO2, capillary blood oxygen saturation.
∗ Corresponding author. Fax: +33 4 91 38 56 38.
E-mail address: alain.fraisse@ap-hm.fr (A. Fraisse).
1875-2136/$ — see front matter © 2009 Elsevier Masson SAS. All rights reserved.
doi:10.1016/j.acvd.2009.09.009
756 M. El Tahlawi et al.
insufﬁciency remained more symptomatic, with three deaths after a median follow-up of 35
(6—97) months and 89% remaining in New York Heart Association class III/IV (vs 29% of patients
without chronic respiratory insufﬁciency; p = 0.035).
Conclusion.— Hypoxaemic shunts are treated effectively by transcatheter closure, resulting
in functional improvement in patients without respiratory insufﬁciency. When associated with
chronic respiratory insufﬁciency, hypoxaemia often persists after shunt closure. In such cases,
the right-to-left atrial shunt does not seem to be the main cause of hypoxaemia and the
indication for closure is questionable.
© 2009 Elsevier Masson SAS. All rights reserved.
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Résumé
Introduction.— Rarement, une hypoxémie peut être associée à l’inversion d’un shunt à l’étage
auriculaire. Sa fermeture par cathétérisme interventionnel est le traitement de choix mais ses
indications et ses résultats ont été peu étudiés.
But.— Décrire notre expérience de la fermeture par cathétérisme de shunt interauriculaire
droite—gauche hypoxémiants et les résultats sur l’oxygénation et l’état clinique des patients.
Méthode.— Étude rétrospective dans les deux centres référents du sud-est de la France de
tous les patients ayant eu la fermeture d’un shunt interatrial droite—gauche associé à une
hypoxémie.
Résultats.— Depuis janvier 2001, 21 patients avec un shunt droite—gauche interatrial ont eu
la fermeture par cathétérisme d’une communication interauriculaire (n = 2) ou d’un foramen
ovale perméable (n = 19) à l’aide d’une prothèse « Amplatzer® ». Trois d’entre eux ont eu des
complications mineures d’évolution favorable et il persistait un shunt résiduel minime chez deux
patients. Les valeurs moyennes de la saturation ainsi que de la pression partielle en oxygène ont
signiﬁcativement augmenté de 86± 5 à 95± 3% (p < 0,001) et de 49,8± 6,8 à 82,9± 30,4mmHg
(p = 0,001), respectivement. Mais la différence de PaO2 (delta PaO2) avant et après ferme-
ture est signiﬁcativement supérieure dans le groupe de patients non insufﬁsants respiratoires
chroniques : +45 (16—91)mmHg contre +8 (4—36)mmHg (p = 0,039). Après un mois, 17 (80 %)
patients rapportent une amélioration clinique mais les insufﬁsants respiratoires restent symp-
tomatiques avec, après un suivi médian de 35 (six à 97) mois, trois décès et 89 % en NYHA III ou
IV contre seulement 29% des autres (p = 0,035).
Conclusion.— Les shunts interauriculaires droite—gauche peuvent être traités efﬁcacement par
cathétérisme, entraînant une amélioration fonctionnelle surtout chez les patients non insuff-
isants respiratoires. Chez ces derniers, l’hypoxémie et les signes cliniques persistent le plus
du sh
. Tou
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ntroduction
he overall incidence of PFO is around 27% [1]. In the major-
ty of cases, PFO does not cause any symptoms. Rarely,
omplications can be associated with cryptogenic strokes
2], and even more rarely with hypoxaemia due to reversal of
nteratrial shunt [3,4]. Several pathophysiological hypothe-
es have been proposed: right ventricular dysfunction or a
ecrease in its compliance; preferential ﬂow from the infe-
ior vena cava towards the left atrium through the interatrial
eptum, sometimes associated with an exuberant eustachian
alve [3]. This is seen readily in patients with CRI, often after
neumonectomy or with ascending aorta aneurysm [5]. Such
atients may develop chronic or intermittent hypoxaemia,
s in the platypnoea-orthodeoxia syndrome (arterial desat-
ration in the upright position), with severe impairment
f their physical capacity. Interventional catheterization
llows PFO closure and therefore abolishes the right-to-
eft shunt responsible for the hypoxaemia [6—8]. However,
hile the feasibility of PFO closure is well demonstrated,
ts indications and results are not well known, in particular
ith regard to severely disabled patients with associated
t
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sunt à cette hypoxémie est difﬁcile à établir.
s droits réservés.
espiratory insufﬁciency. We analysed retrospectively indi-
ations and patient outcomes after such closures in two
entres.
atients and methods
opulation from December 1999 to December 2006, all
atients in La Timone Hospital and Saint-Joseph’s Hospital,
arseille, France, who underwent transcatheter PFO or ASD
losure for hypoxaemia associated with a right-to-left atrial
hunt, were included.
ransoesophageal echocardiography
or each patient, the diagnosis of PFO or ASD was conﬁrmed
y transoesophageal echocardiography with contrast injec-
ion (Levovist®). All patients had a right-to-left interatrial
hunt, spontaneously or during Vasalva manoeuvre. The
resence of an atrial septal aneurysm, detected by move-
ent of the atrial septum more than 10mm in M-mode, was
ought systematically. Transoesophageal echocardiography
757
F
a
r
c
ﬁ
(
e
(
t
h
a
c
p
a
A
3
s
I
a
n
p
pHypoxemic patent foramen ovale closure
control was carried out systematically 1 month after
closure, to search for a residual shunt by colour Doppler
and contrast injection.
Cardiac catheterization
The transcatheter PFO closure was performed under local
anaesthesia or mild sedation after puncture of the right
femoral vein and placement of an 8 French sheath. All
patients were anticoagulated with unfractionated heparin
(100 IU/kg to a maximum of 5000 IU). Anticoagulation was
continued for 12 h, then replaced by antiplatelet treatment
for 6 months. A balloon occlusion test was performed in nine
of our 10 ﬁrst patients, then it was decided to do it only
in the setting of elevated right atrial pressure (>20mmHg),
which was not encountered in the subsequent cases. The
devices used for shunt closure were an Amplatzer (AGA Med-
ical, Golden Valley, MN, USA) 25mm PFO occluder (n = 6),
an Amplatzer 35mm PFO occluder (n = 13), and Amplatzer
20mm and 26mm septal occluders for the two ASDs. The
devices were implanted according to the method described
previously [7]. The procedure, performed under ﬂuoroscopy,
was guided by transoesophageal, transthoracic or intrac-
ardiac echocardiography with the Acunav® system (Acunav
Diagnostic Ultrasound Catheter, CA, USA) [9]. SaO2 and PaO2
were measured before and 24 h after closing the shunt under
initial measurement conditions.
Statistical analysis values are expressed as
means± standard deviations or medians (ranges) when
appropriate. Patients were grouped according to the
presence or absence of respiratory insufﬁciency. Statistical
analysis was performed using with Microsoft Excel software,
version 2007 (Microsoft Corp., Seattle, WA, USA) and JMP
version 7.0 (SAS Institute, Cary, NC, USA). Patients with
respiratory insufﬁciency were compared with other patients
using the Mann-Whitney and Wilcoxon tests. A p-value < 0.05
was considered signiﬁcant.
Results
Twenty-one patients (11 men) underwent transcatheter PFO
(n = 19) or ASD (n = 2) closure for hypoxaemia associated with
a right-to-left atrial shunt (Table 1). The patients were diag-
nosed at a mean age of 65.5± 9.8 years. In ﬁve patients,
the PFO was associated with an aneurysm of the intera-
trial septum. The patients experienced dyspnoea at minimal
exertion (n = 13) or orthopnoea in 33% of cases (n = 8), neces-
sitating transient or continuous oxygen supplement in all
Table 1 Population characteristics before closure of
interatrial shunt.
Characteristic Mean± standard deviation
Age (years) 65.4 ± 9.8
Weight (kg) 74.0 ± 19.3
Systolic pulmonary artery
pressure (mmHg)
32.0 ± 9.4
Haemoglobin (g/dL) 14.6 ± 2.3
Haematocrit (%) 45.9 ± 6.6
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eigure 1. Difference in partial oxygen arterial pressure (PaO2)
fter right-to-left interatrial shunt closure in patients with chronic
espiratory insufﬁciency (CRI) and those without CRI (N).
ases. Nine (43%) patients had chronic respiratory insuf-
ciency, including obstructive bronchopulmonary disease
n = 5), pneumoconiosis (n = 2), interstitial pulmonary dis-
ase (n = 1) and chronic pulmonary thromboembolic disease
n = 1). Two patients had mild pulmonary hypertension (sys-
olic pulmonary artery pressure of 55mmHg). Two patients
ad a history of pneumonectomy, whereas one had an
neurysm of the ascending aorta. Four patients had poly-
ythaemia (17—18 g/dL). The hypoxaemia was severe in all
atients, with a mean SaO2 of 86± 5%. The PaO2 conﬁrmed
marked hypoxia, with a mean PaO2 of 49.8± 6.8mmHg.
ll patients were dyspnoeic with 62% in NYHA class III and
8% in NYHA class IV. Two women with an ASD had their tran-
catheter closure at 73 and 69 years and were in NYHA class
II and IV, respectively; their PaO2 measurements were 53
nd 43mmHg, respectively. Their coronary angiograms were
ormal and right heart catheterization conﬁrmed normal
ulmonary artery pressure with systolic pulmonary artery
ressures of 35 and 30mmHg, respectively.
Transcatheter closure was achieved in all patients. Three
14%)minor complications occurred: a transient atrial ﬂutter
hat resolved spontaneously and two groin haematomas. The
ean SaO2 rose from 86± 5 to 95± 3% (p < 0.001). The mean
aO2 rose from 49.8± 6.8 to 82.9± 30.4mmHg (p = 0.001).
he difference in PaO2 (PaO2) before and after closure was
igniﬁcantly higher in the group of patients who did not have
RI: +45 (16—91) versus +8 (4—36)mmHg in patients with
RI (p = 0.039) (Fig. 1). Transoesophageal echocardiography
ontrol 1 month after PFO closure showed a minimal resid-
al interatrial shunt in two (9.5%) patients without residual
ypoxaemia. One month after the procedure, dyspnoea had
mproved in 17 (80%) patients.
After a median follow-up of 35 (6—97) months, three
atients in the CRI group had died from their associated
omorbidities (two from terminal respiratory insufﬁciency
nd the third from lung cancer); there were no reported
mbolic events and CRI patients were more symptomatic,
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Figure 2. Percentage of patients in New York Heart Association
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cNYHA) class III or IV before and after right-to-left shunt closure
n patients with chronic respiratory insufﬁciency (CRI) and those
ithout CRI (N).
ith 89% in NYHA class III or IV (whereas only 29% of non-CRI
atients were in NYHA class III or IV; p = 0.035) (Fig. 2).
iscussion
ypoxaemic interatrial shunts are reported rarely and may
e underestimated and underdiagnosed. Our series included
ases similar to previously reported studies [3,6—8]. Men and
omen seem to be affected equally, and the age at diagnosis
s rather late:
44—79 years in our study;
59—78 years for Godart et al. [3];
56—78 years for Guerin et al. [6];
52—64 years for Seward et al. [10].
The clinical proﬁle was also quite similar to that found in
revious studies.
In our study, only two (9%) patients had mild pulmonary
ypertension. This is in agreement with the study by Godart
t al., investigating the possibility of right-to-left shunt in
he absence of elevated pulmonary artery pressure [3]. In
his patient population, the direction of the shunt at the
trial level depends highly on the relaxation and compli-
nce of the two ventricles during diastole. Reduced diastolic
unction of the right ventricle with elevated end-diastolic
ressure was the primary cause of right-to-left atrial shunt in
recent study [11]. Hence, patients with pulmonary hyper-
ension will shunt right-to-left at the atrial level only when
he right ventricle becomes hypertrophied, and eventually
ilated, with reduced diastolic function [3,11,12]. This is
ikely to be the main hypothesis to explain the right-to-
eft atrial shunt in the two patients with an ASD in our
tudy. In the setting of a PFO, three additional hypotheses
re currently advanced, besides the ratio of ﬁlling pres-
ure between the two ventricles. Firstly, modiﬁcation of the
eometry of intracardiac structures after pneumonectomy
r dilatation of the ascending aorta results in rocking of
nteratrial septum towards the oriﬁce of the inferior vena
ava and then promotes a right-to-left shunt [5]. This mech-
nism can be exacerbated by an exuberant eustachian valve
3]. Secondly, the presence of a paroxysmal right atrium-
o-left atrial gradient [3]. Thirdly, hypoxaemia might also
e related to extrinsic compression of the right atrium,
specially in the upright position, causing an increase in
t
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ressures in the right side of the heart. Depending on the
nderlying disorders, the compression may be the result
f a right hydrothorax or a localized pericardial effusion.
ompression of the right atrium by a right hydrothorax may
lay a role after right-sided pneumonectomy [13].
Such assumptions have not been studied precisely in our
eries, although we found a signiﬁcant proportion of patients
ith pneumonectomy (10%) or ascending aorta aneurysm
5%). Careful analysis of a computed tomography scan may
elp to better elucidate the link between right-to-left atrial
hunt and modiﬁcation of the geometry of the intracardiac
tructure and/or extrinsic compression of the right atrium.
In our present study, we found a signiﬁcant propor-
ion (43%) of patients with CRI. Whereas the PFO closure
eemed to be highly effective in our patients, with most
80%) showing improvement in oxygenation variables, such
mprovement was not observed in the CRI patients, who
ere still dyspnoeic, and most remained in NYHA class III
r IV. We hypothesize that the hypoxaemia in CRI patients
ccurs predominantly through an intrapulmonary shunt asso-
iated with their respiratory illness. Although a right-to-left
hunt is often associated with CRI due to associated acquired
natomic factors (such as pneumonectomy), its participa-
ion in the patient’s hypoxaemia seems to be relatively
inor. Unfortunately, transoesophageal echocardiography
s a diagnostic tool cannot quantify precisely the part of the
ypoxaemia that is due to the extrapulmonary shunt related
o the PFO or ASD, compared with the intrapulmonary shunt
aused by the CRI. Another interesting method of investiga-
ion, in theory, is respiratory function testing. However, this
est has produced disappointing results in our experience. In
RI patients, PFO closure only reverses the hypoxaemia par-
ially and obviously does not prevent the potentially fatal
utcome of the respiratory disease, as illustrated by the
hree deaths in our study. Based on our study ﬁndings, the
ndication for PFO closure in CRI patients remains contro-
ersial.
All our study patients were in NYHA class III or IV before
hunt closure vs 44.8% in the series of Guerin et al. [6].
his advancing NYHA grade with profound cyanosis at rest
eﬂects a profoundly debilitating general condition. Con-
equently, most of our study patients were likely to be
nable to perform any functional assessment, such as a
-min walking test, appropriately. Moreover, the result of
uch testing would not modify the indication for PFO clo-
ure. In addition, 16/21 of the patients were referred to
ur department by pneumonologists for urgent or semi-
rgent PFO closure. Finally, we had nearly 38% of patients
ith platypnoea-orthodeoxia syndrome, and interpretation
f a 6-min walking test in patients who experience upright
ypoxaemia would be difﬁcult.
From a technical point of view, percutaneous closure
as achieved in all patients, which corresponds to data
rom the literature suggesting an effective closure rate of
5—100% [3,6—8,14]. In our study, few (14%) patients expe-
ienced complications during transcatheter closure; these
omplications were minor, in the form of transient supraven-
ricular arrhythmias (atrial ﬁbrillation and ﬂutter) and groin
aematomas. However, more serious adverse events may
ccur. One cerebrovascular accident that resolved within 1
onth after closure was reported in by Godart et al. [3].
egarding the efﬁciency of the procedure, our small residual
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shunt rate of 9.5% is similar to the 6% reported by Guerin et
al. [6]. Godart et al., Rao et al. and Delgado et al. reported
higher minor residual shunt rates without the need for rein-
tervention: 9% [3], 50% [7] and 16% [15], respectively. In the
study by Guerin et al., one patient with a signiﬁcant residual
shunt needed the implantation of a second device [6].
Conclusion
Hypoxaemic shunts are treated effectively by transcatheter
closure. Their closure is often associated with functional
improvement and amelioration of the hypoxaemia, except
in CRI patients. In such cases, the right-to-left atrial shunt
does not seem to be the main cause of the hypoxaemia and
the indication for PFO or ASD closure in these patients is
questionable.
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